| Primary |
| Drug Use For Unknown Indication |
31.4% |
| Product Used For Unknown Indication |
18.1% |
| Pain |
7.3% |
| Rheumatoid Arthritis |
6.5% |
| Back Pain |
5.9% |
| Hypertension |
4.2% |
| Arthritis |
3.7% |
| Arthralgia |
3.1% |
| Ankylosing Spondylitis |
2.8% |
| Osteoarthritis |
2.5% |
| Fibromyalgia |
2.3% |
| Osteoporosis |
1.7% |
| Tendon Disorder |
1.7% |
| Atrial Fibrillation |
1.4% |
| Depression |
1.4% |
| Multiple Sclerosis |
1.4% |
| Diabetes Mellitus |
1.1% |
| Gout |
1.1% |
| Pain In Extremity |
1.1% |
| Spondylitis |
1.1% |
|
| Nausea |
8.3% |
| Rectal Haemorrhage |
8.3% |
| Melaena |
6.9% |
| Breast Mass |
5.6% |
| Rash |
5.6% |
| Upper Gastrointestinal Haemorrhage |
5.6% |
| Vulval Disorder |
5.6% |
| Weight Decreased |
5.6% |
| Abortion Spontaneous |
4.2% |
| Epistaxis |
4.2% |
| Faeces Discoloured |
4.2% |
| Gastric Ulcer |
4.2% |
| Haematemesis |
4.2% |
| International Normalised Ratio Increased |
4.2% |
| Pruritus |
4.2% |
| Renal Failure |
4.2% |
| Renal Impairment |
4.2% |
| Staphylococcal Infection |
4.2% |
| Urinary Tract Infection |
4.2% |
| Amnesia |
2.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
19.4% |
| Product Used For Unknown Indication |
14.1% |
| Pain |
10.7% |
| Rheumatoid Arthritis |
7.2% |
| Arthritis |
4.5% |
| Fibromyalgia |
4.5% |
| Ankylosing Spondylitis |
4.4% |
| Convulsion |
3.9% |
| Hypertension |
3.9% |
| Ill-defined Disorder |
3.9% |
| Osteoarthritis |
3.8% |
| Back Pain |
3.3% |
| Arthralgia |
2.7% |
| Inflammation |
2.6% |
| Paraesthesia |
2.1% |
| Multiple Sclerosis |
2.0% |
| Prophylaxis |
2.0% |
| Epilepsy |
1.8% |
| Pain In Extremity |
1.8% |
| Juvenile Arthritis |
1.7% |
|
| Drug Hypersensitivity |
20.8% |
| Weight Increased |
8.1% |
| Drug Ineffective |
7.4% |
| Nausea |
6.0% |
| Vomiting |
6.0% |
| Weight Decreased |
4.7% |
| White Blood Cell Count Decreased |
4.7% |
| Abortion Spontaneous |
4.0% |
| Gastrointestinal Haemorrhage |
4.0% |
| Urinary Tract Infection |
4.0% |
| Venous Thrombosis Limb |
4.0% |
| Oedema Peripheral |
3.4% |
| Swelling |
3.4% |
| Tachycardia |
3.4% |
| Renal Disorder |
2.7% |
| Renal Failure Acute |
2.7% |
| Renal Impairment |
2.7% |
| Toxic Epidermal Necrolysis |
2.7% |
| Tubulointerstitial Nephritis |
2.7% |
| Ventricular Tachycardia |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.1% |
| Drug Use For Unknown Indication |
19.2% |
| Rheumatoid Arthritis |
11.1% |
| Pain |
9.7% |
| Hypertension |
4.3% |
| Depression |
4.1% |
| Anxiety |
2.7% |
| Osteoporosis |
2.6% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Arthritis |
2.3% |
| Breast Cancer |
2.2% |
| Contraception |
2.2% |
| Back Pain |
2.1% |
| Insomnia |
2.1% |
| Multiple Sclerosis |
2.0% |
| Asthma |
1.8% |
| Multiple Myeloma |
1.7% |
| Arthralgia |
1.6% |
| Psoriatic Arthropathy |
1.4% |
| Juvenile Arthritis |
1.3% |
|
| Weight Decreased |
13.8% |
| Pulmonary Embolism |
10.6% |
| Vomiting |
10.5% |
| Weight Increased |
7.8% |
| Pain |
7.7% |
| Deep Vein Thrombosis |
5.2% |
| Type 2 Diabetes Mellitus |
4.5% |
| Vision Blurred |
4.3% |
| Nausea |
3.4% |
| Injection Site Pain |
3.3% |
| Pain In Extremity |
3.2% |
| Myocardial Infarction |
3.1% |
| Drug Ineffective |
3.0% |
| Oedema Peripheral |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
| Urinary Tract Infection |
2.9% |
| Sepsis |
2.8% |
| Urticaria |
2.8% |
| Pyrexia |
2.6% |
| Paraesthesia |
2.4% |
|
| Interacting |
| Stent Placement |
37.5% |
| Back Pain |
18.8% |
| Grand Mal Convulsion |
12.5% |
| Arthropathy |
6.3% |
| Coronary Arterial Stent Insertion |
6.3% |
| Fibromyalgia |
6.3% |
| Inflammation |
6.3% |
| Pain |
6.3% |
|
| Staphylococcal Infection |
27.3% |
| Drug Interaction |
18.2% |
| Urinary Tract Infection |
18.2% |
| Feeling Abnormal |
9.1% |
| Musculoskeletal Discomfort |
9.1% |
| Skin Ulcer |
9.1% |
| Swelling Face |
9.1% |
|
